These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10520641)

  • 21. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of the chemokine receptor CCR5 in the development of American cutaneous leishmaniasis in a Southern Brazilian population.
    Ribas AD; Ribas RC; Da Silva Júnior WV; Aristides SM; Lonardoni MV; Watanabe MA; Borelli SD; Silveira TG
    Mol Med Rep; 2013 Jul; 8(1):189-94. PubMed ID: 23632983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The case for selection at CCR5-Delta32.
    Sabeti PC; Walsh E; Schaffner SF; Varilly P; Fry B; Hutcheson HB; Cullen M; Mikkelsen TS; Roy J; Patterson N; Cooper R; Reich D; Altshuler D; O'Brien S; Lander ES
    PLoS Biol; 2005 Nov; 3(11):e378. PubMed ID: 16248677
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The chemokine receptor CCR5 Δ32 allele in natalizumab-treated multiple sclerosis.
    Møller M; Søndergaard HB; Koch-Henriksen N; Sorensen PS; Sellebjerg F; Oturai AB
    Acta Neurol Scand; 2014 Jan; 129(1):27-31. PubMed ID: 23668375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of 32 alelle of the CCR5 gene in the population of Poland.
    Jagodzinski PP; Lecybył R; Ignacak M; Juszczyk J; Trzeciak WH
    J Hum Genet; 2000; 45(5):271-4. PubMed ID: 11043507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of CCR5-delta32 and CCR2-64I alleles on disease progression of perinatally HIV-1-infected children: an international meta-analysis.
    Ioannidis JP; Contopoulos-Ioannidis DG; Rosenberg PS; Goedert JJ; De Rossi A; Espanol T; Frenkel L; Mayaux MJ; Newell ML; Pahwa SG; Rousseau C; Scarlatti G; Sei S; Sen L; O'Brien TR;
    AIDS; 2003 Jul; 17(11):1631-8. PubMed ID: 12853745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCR5 genotyping in an Australian and New Zealand type 1 diabetes cohort.
    Buhler MM; Craig M; Donaghue KC; Badhwar P; Willis J; Manolios N; Tait BD; Silink M; Bennetts BH; Stewart GJ
    Autoimmunity; 2002 Nov; 35(7):457-61. PubMed ID: 12688247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship between CCR5
    Martínez-Bonet M; González-Serna A; Clemente MI; Morón-López S; Díaz L; Navarro M; Puertas MC; Leal M; Ruiz-Mateos E; Martinez-Picado J; Muñoz-Fernández MA
    Clin Microbiol Infect; 2017 May; 23(5):318-324. PubMed ID: 28042001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using the distribution of the CCR5-Δ32 allele in third-generation Maltese citizens to disprove the Black Death hypothesis.
    Baron B; Schembri-Wismayer P
    Int J Immunogenet; 2011 Apr; 38(2):139-43. PubMed ID: 21156032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CCR5 Delta32 deletion and atopic asthma in India.
    Batra J; Sharma M; Chatterjee R; Sharma S; Mabalirajan U; Ghosh B
    Thorax; 2005 Jan; 60(1):85. PubMed ID: 15618591
    [No Abstract]   [Full Text] [Related]  

  • 31. Frequency of the CCR5-Delta32 mutant allele is not increased in Belgian hepatitis C virus-infected patients.
    Thoelen I; Verbeeck J; Wollants E; Maes P; Robaeys G; Matheï C; Buntinx F; Nevens F; Van Ranst M
    Viral Immunol; 2005; 18(1):232-5. PubMed ID: 15802968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution of four HIV type 1-resistance polymorphisms (CCR5-Delta32, CCR5-m303, CCR2-64I, and SDF1-3'A) in the Bahraini population.
    Salem AH; Farid E; Fadel R; Abu-Hijleh M; Almawi W; Han K; Batzer MA
    AIDS Res Hum Retroviruses; 2009 Oct; 25(10):973-7. PubMed ID: 19803715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The combination of primary sclerosing cholangitis and CCR5-Δ32 in recipients is strongly associated with the development of nonanastomotic biliary strictures after liver transplantation.
    op den Dries S; Buis CI; Adelmeijer J; Van der Jagt EJ; Haagsma EB; Lisman T; Porte RJ
    Liver Int; 2011 Sep; 31(8):1102-9. PubMed ID: 21134114
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
    Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX
    Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients.
    Melum E; Karlsen TH; Broomé U; Thorsby E; Schrumpf E; Boberg KM; Lie BA
    Tissue Antigens; 2006 Jul; 68(1):78-81. PubMed ID: 16774544
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
    Prahalad S
    Genes Immun; 2006 Apr; 7(3):264-8. PubMed ID: 16541097
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CC chemokine receptor 5 Δ32 polymorphism: association analysis and allele distribution among cutaneous leishmaniasis patients from Pakistan.
    Sophie M; Hameed A; Muneer A; Samdani AJ; Saleem S; Azhar A
    J Cutan Pathol; 2016 Jul; 43(7):564-70. PubMed ID: 26970327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of chemokine receptor 5 (CCR5) delta32 mutation with Behçet's disease is dependent on gender in Iranian patients.
    Mojtahedi Z; Ahmadi SB; Razmkhah M; Azad TK; Rajaee A; Ghaderi A
    Clin Exp Rheumatol; 2006; 24(5 Suppl 42):S91-4. PubMed ID: 17067435
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association between the chemokine receptor 5 delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
    Lee YH; Bae SC; Song GG
    Mod Rheumatol; 2013 Mar; 23(2):304-10. PubMed ID: 22638733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women.
    Pai JK; Kraft P; Cannuscio CC; Manson JE; Rexrode KM; Albert CM; Hunter D; Rimm EB
    Atherosclerosis; 2006 May; 186(1):132-9. PubMed ID: 16055130
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.